Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
XaTek
Cleveland, Ohio, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
XaTek is developing ClotChip, a portable point-of-care in vitro diagnostic device that uses miniaturized dielectric spectroscopy on a finger-stick whole-blood sample to provide quantitative and qualitative assessment of a patient's global hemostatic (clotting) profile. ClotChip has received FDA Breakthrough Device designation and is undergoing clinical studies for use across multiple bleeding and anticoagulation management settings.[1][4][8]
- Therapeutic areas
- Hematology
- Modalities
- DeviceNon-pharmacological therapy
- Industry
- Protein Biomarker Diagnostics
02
Partnerships
Cleveland Clinic Innovations incubator client/partner[2]U.S. Navy collaboration to prepare ClotChip handheld coagulation reader for operational use[7]
Beyond the preview
Go deeper on XaTek.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on XaTek.